Delivery Order SPE2DB22D3501-SPE2DB24FVW70

Award Date 6/5/24
Potential Completion Date 6/6/24
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $70,916.11, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of RIFAMPIN 300 MG CAPSULE 30S, a pharmaceutical product, with a completion date of February 25, 2025. The contract is a Firm Fixed Price arrangement, and there is no set-aside designation indicated. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, valued at $1,496.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567377584 - RIFAMPIN 300 MG CAPSULE 60S, a pharmaceutical product. The contract is a Delivery Order under an existing Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,981.65 firm-fixed-price delivery order contract is for the supply of 4564885228 - RIFAMPIN 300 MG CAPSULE 60S. This award is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, valued at $2,746.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of RIFAMPIN 300 MG CAPSULE 60S, a pharmaceutical product. The contract has an Ultimate Completion Date of July 19, 2024 and a Ceiling Value of $2,746.58. It is a Firm Fixed Price contract, with no set-aside designation. AmerisourceBergen Drug Corp...
This federal contract award, valued at $14,006.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,566,456,180 units of Rifampin 300 mg capsules. The contract is not set aside for any specific business category. It is an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
The federal contract award provides Amerisourcebergen Drug Corp, a major pharmaceutical distributor, with a Delivery Order valued at $30,687.90 to supply 4,566,487,325 units of Rifampin 300 mg capsules to the Defense Logistics Agency (DLA). This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $6,104.37 and covers the delivery of rifampin 300mg capsules. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 27, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $4,018.20, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for 4,567,282,910 units of the drug Rifampin 300 mg Capsule, with a completion date of February 18, 2025. The contract is a firm-fixed-price type with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $2,224.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of 60 capsules of 300 mg Rifampin, a common antibiotic medication. The contract has an ultimate completion date of December 29, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) to provide 4564731036 RIFAMPIN 300 MG CAPSULE 60S. The contract has a ceiling value of $11,453.75 and an ultimate completion date of May 29, 2024. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FVW70
    Delivery Order

This federal contract award, valued at $2,453.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4564816476 - Rifampin 300 mg Capsule 60s, a pharmaceutical product, with a completion date of June 6, 2024.

Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide.

The contract does not have a set-aside designation, indicating it was awarded on a full and open competition basis. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 9/4/24, 9:16 AM